EUVIMEDEUVIMED entdecken
Fallbericht

Effective application of a direct-acting oral anticoagulants reversal agent in acute type A aortic dissection repair: A case report

Tatsuto Wakami iD, Naoto Fukunaga iD, Akio Shimoji, Nobushige Tamura

Asian Cardiovascular and Thoracic Annals · 2024

DOI: 10.1177/02184923241237300 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Asian Cardiovascular and Thoracic Annals, 2024. Verfasst von Tatsuto Wakami und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan. Hauptthemen laut MEDLINE: Aortic Dissection, Factor Xa Inhibitors, Blood Vessel Prosthesis Implantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are insufficient reports on the use of andexanet alfa in cardiac surgery. A 67-year-old man was diagnosed with type A aortic dissection and performed emergent surgery. His medical history included atrial fibrillation treated with Edoxaban. We performed total arch replacement. Despite administration of enough protamine, fresh frozen plasma, and platelet administration, controlling bleeding was difficult. Thus, Andexanet Alfa was initiated after CPB withdrawal. Surgical bleeding was dramatically controlled after its administration. There were no findings suggestive of an embolic event. In conclusion, administration of Andexanet Alfa is safe after cardiopulmonary bypass withdrawal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic DissectionFactor Xa InhibitorsBlood Vessel Prosthesis ImplantationHumansMaleAgedTreatment OutcomeAdministration, OralRecombinant ProteinsAortic Aneurysm, ThoracicCardiopulmonary BypassBlood Loss, SurgicalAcute DiseaseFactor XaAortic Aneurysm

Stichwörter der Autor:innen

Andexanet alfaaorticaortic dissectioncardiopulmonary bypassdirect-acting oral anticoagulantsdiseasegeneral

Substanzen

Factor Xa InhibitorsPRT064445Recombinant ProteinsFactor Xa

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan.

ORCID-Profile: Tatsuto Wakami, Naoto Fukunaga

Zitieren

APA

Wakami, T., Fukunaga, N., Shimoji, A., & Tamura, N. (2024). Effective application of a direct-acting oral anticoagulants reversal agent in acute type A aortic dissection repair: A case report. Asian Cardiovascular and Thoracic Annals. https://doi.org/10.1177/02184923241237300

Vancouver

Wakami T, Fukunaga N, Shimoji A, Tamura N. Effective application of a direct-acting oral anticoagulants reversal agent in acute type A aortic dissection repair: A case report. Asian Cardiovascular and Thoracic Annals. 2024. doi:10.1177/02184923241237300

BibTeX
@article{Wakami2024,
  author = {Wakami, Tatsuto and Fukunaga, Naoto and Shimoji, Akio and Tamura, Nobushige},
  title = {Effective application of a direct-acting oral anticoagulants reversal agent in acute type A aortic dissection repair: A case report},
  journal = {Asian Cardiovascular and Thoracic Annals},
  year = {2024},
  doi = {10.1177/02184923241237300}
}
Kostenlos starten →